FDA Inspection 1280332 — Supernus Pharmaceuticals, Inc.
The FDA completed an inspection of Supernus Pharmaceuticals, Inc. on July 31, 2025 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rockville, MD (United States)